Emerging Therapeutics: APOL1-Mediated Kidney Disease

Emerging Therapeutics for APOL1-Mediated Kidney Disease A GlomCon interview with Dr. Rasheed A. Gbadegesin Supported through an educational grant from Vertex Pharmaceuticals Join us at network.glomcon.org and my.glomcon.org Visit us at www.glomcon.org